Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: Is that a latent disadvantage?

Figure 2

Fenofibrate alleviates dyslipidemia in obese MSG rats. Fasting cholesterol, triglyceride and major lipoproteins levels were assayed on 4th week. Nor, normal rats. Con, water treated obese MSG rats. Fen, fenofibrate treated obese MSG rats. Values represented means ± s.e.m. (n = 10-12). *p < 0.05, **p < 0.01, ***p < 0.001 vs. control.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us